Angela Justice

Chief People Officer • TCR2 Therapeutics

Dr. Justice is a visionary, award-winning executive focused on scaling organizations, aligning talent, and driving outcomes through key inflection points within complex, fast-growing, and highly regulated organizations. With over 20 years of experience in healthcare and biotech, Dr. Justice has a unique ability to quickly assess business context and develop customized solutions that get rapid, meaningful, and sustainable results. She is currently the Chief People Officer of TCR2 Therapeutics where she has led the company through significant growth, driven meaningful increases in diversity, and built a vibrant and scalable culture. Prior to joining TCR2, she was the Executive Vice President and Chief Human Resources Officer at Surgery Partners where launched a multi-year talent strategy to incentivize organic growth. Before that, Dr. Justice worked at Biogen as the Chief Learning Officer where she created and led a centralized learning organization supporting 14,000 people across all departments and geographies, made learning a competitive force with measurable business impact, and was an active member of the Human Resources Leadership Team. Earlier at Biogen, Angela served as Senior Director of Global Medical Affairs where she supported the launch of 6 therapies across multiple therapeutic areas and geographies. Previously, she held leadership roles at EMD Serono, the National MS Society, and was a management consultant at McKinsey & Company. Dr. Justice received her Ph.D. in Biopsychology from the University of Chicago.

Also speaking

Michael Leek

Executive Chairman & Founder • TC Biopharm

Nicholas Medcalf

Deputy Challenge Director for the Medicines Manufacturing Challenge • Innovate UK

Silvio Weber

Director Industrial Workflow Development, Cellular Therapy • Miltenyi Biotec

Event Info


2022 Spotlight Roundtables

Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.